| Financial Year |
March 31 2023 |
| Monetary Funds |
917,253,782.81 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
5,914,450.25 |
| Accounts Receivable |
986,093,921.14 |
| Advances to Suppliers |
86,143,735.80 |
| Other Receivables |
138,261,984.41 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
36,000,000.00 |
| Inventories |
323,498,333.02 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
121,257,366.20 |
| Total Current Assets |
3,839,606,272.52 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,088,692,744.11 |
| Investment Properties |
-- |
| Fixed Assetes |
762,907,176.36 |
| Under-construction Projects |
443,891,421.88 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
477,176,536.94 |
| R&D expenses |
38,042,365.85 |
| Goodwill |
17,905,317.24 |
| Long-Term Deferred and Prepaid Expenses |
16,732,023.09 |
| Deferred Income Tax Assets |
94,949,345.76 |
| Other Non-Current Assets |
25,572,649.01 |
| Sub-Total of Non-Current Assets |
3,181,687,886.41 |
| Total Assets |
7,021,294,158.93 |
| Short-Term Loans |
394,068,983.07 |
| Trading Financial liabilities |
-- |
| Notes Payable |
374,284,934.44 |
| Accounts Payable |
1,701,098,657.07 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
26,109,324.85 |
| Taxes Payable |
11,904,018.87 |
| Interest Payable |
-- |
| Dividend Payable |
27,840,337.56 |
| Other payables |
69,347,798.61 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
460,636,690.34 |
| Other Current Liabilities |
6,502,672.49 |
| Sub-Total of Current Liabilities |
3,112,902,104.92 |
| Long-term Loans |
827,182,726.38 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,166,046.15 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
881,526,685.15 |
| Total Liabilities |
3,994,428,790.07 |
| Paid-In Capital(Or Share Stock) |
561,084,262.00 |
| Capital Surplus |
2,016,402,978.20 |
| Surplus Reserve |
36,524,457.32 |
| LESS:Treasury Stock |
121,469,414.29 |
| Undistributed Profits |
281,394,112.03 |
| Minority Stockholder's Interest |
265,372,311.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,761,493,057.86 |
| Owner's Equity（Stockholder's Equity） |
3,026,865,368.86 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,021,294,158.93 |
